
    
      This is a study to asses the safety and tolerability of single and multiple ascending doses
      of EP395, administered by oral capsules, in healthy subjects with the aim to determine the
      safe dose range of EP395 for further clinical development. The study consists of two parts,
      part A where single-ascending doses will be assessed and part B where multiple-ascending
      doses will be assessed. The primary objective being safety and tolerability as well as the
      pharmacokinetic properties of EP395.
    
  